⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Elyse MandellAPRN, BC

Nurse Practitioner · Boston, MA 02115

NPI: 1407893712

Share:

37

🟠 Elevated

Risk Flags

High opioid rate vs specialty peers90th percentile opioid prescribingExtreme cost outlier (population + peer)High brand-name preferenceHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

692

Total Claims

$1.3M

Drug Cost

68

Beneficiaries

$19K

Cost/Patient

Risk Score Breakdown 37/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+10
Cost per patient outlier+10
Long-acting opioid rate+8
Opioid rate (national percentile)+5
Brand-name preference+4

Score components are additive. Read full methodology

Peer Comparison vs. 218,535 Nurse Practitioner providers

+806%

Opioid rate vs peers

34.2% vs 3.8% avg

+1514%

Cost per patient vs peers

$19K vs $1,174 avg

+368%

Brand preference vs peers

41.5% vs 8.9% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 806% above the average for Nurse Practitioner providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

💰

Cost per patient is 1514% above the specialty average. Extreme cost outliers may indicate prescribing of unnecessarily expensive brand-name drugs or inappropriate drug utilization.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

34.2%

Opioid Rate

237

Opioid Claims

$18K

Opioid Cost

28.7%

Long-Acting Rate

This provider's opioid prescribing rate of 34.2% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

59% generic

Brand: 287 claims · $1.2M

Generic: 405 claims · $75K

Patient Profile

60

Avg Age

63%

Female

3.63

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About